Antiplatlet Therapy

      -In ACS and PCI: Challenges and Future Directions by Dr. Stephen D. Wiviott (2007)

      -Use After Discharge Among Acute Myocardial Infarction Patients with In-Hospital Bleeding by Dr. Tracy Y. Wang (2008)

Clopidogrel Non-responsiveness

      -Clinical Implications of Clopidogrel Non-responsiveness by Dr. Dominick Angiolillo (2007)

TRITON TIMI-38 STEMI: Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel - Thrombolysis In Myocardial Infarction 38

      -Clopidogrel Under Fire: Is Prasugrel in Primary PCI or Recent MI Superior? Insights From TRITON TIMI-38 by Dr. Gilles Montalescot, et al.

      -The Risk of CV Events for Patients Treated with Clopidogrel or Prasugrel in Combination with a Proton Pump Inhibitor: Results from the TRITON-TIMI 38 Trial by Dr. Michelle O'Donoghue, et al. (ESC 2009)

      -TRITON-TIMI 38 Economic Substudy: Cost-effectiveness of Prasugrel vs. Clopidogrel for PCI Patients with Acute Coronary Syndromes by Dr. David J. Cohen, et al.

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster